OGEN
Price
$1.09
Change
-$0.01 (-0.91%)
Updated
Aug 28, 04:12 PM (EDT)
Capitalization
4.62M
REVB
Price
$2.74
Change
+$0.01 (+0.37%)
Updated
Aug 28, 04:17 PM (EDT)
Capitalization
4.74M
Interact to see
Advertisement

OGEN vs REVB

Header iconOGEN vs REVB Comparison
Open Charts OGEN vs REVBBanner chart's image
Oragenics
Price$1.09
Change-$0.01 (-0.91%)
Volume$300
Capitalization4.62M
Revelation Biosciences
Price$2.74
Change+$0.01 (+0.37%)
Volume$333
Capitalization4.74M
OGEN vs REVB Comparison Chart in %
Loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGEN vs. REVB commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGEN is a StrongBuy and REVB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (OGEN: $1.10 vs. REVB: $2.73)
Brand notoriety: OGEN and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OGEN: 3% vs. REVB: 36%
Market capitalization -- OGEN: $4.62M vs. REVB: $4.74M
OGEN [@Biotechnology] is valued at $4.62M. REVB’s [@Biotechnology] market capitalization is $4.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGEN’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • OGEN’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, REVB is a better buy in the long-term than OGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGEN’s TA Score shows that 4 TA indicator(s) are bullish while REVB’s TA Score has 5 bullish TA indicator(s).

  • OGEN’s TA Score: 4 bullish, 3 bearish.
  • REVB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both OGEN and REVB are a good buy in the short-term.

Price Growth

OGEN (@Biotechnology) experienced а +1.85% price change this week, while REVB (@Biotechnology) price change was +7.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.33%. For the same industry, the average monthly price growth was +14.94%, and the average quarterly price growth was +30.68%.

Industries' Descriptions

@Biotechnology (+2.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REVB($4.74M) and OGEN($4.62M) have the same market capitalization . REVB (-87.663) and OGEN (-90.071) have similar YTD gains . REVB has higher annual earnings (EBITDA): -8.08M vs. OGEN (-9.51M). REVB has more cash in the bank: 5.17M vs. OGEN (1.97M). REVB has less debt than OGEN: REVB (0) vs OGEN (3M). OGEN (0) and REVB (0) have equivalent revenues.
OGENREVBOGEN / REVB
Capitalization4.62M4.74M98%
EBITDA-9.51M-8.08M118%
Gain YTD-90.071-87.663103%
P/E RatioN/A0.00-
Revenue00-
Total Cash1.97M5.17M38%
Total Debt3M0-
FUNDAMENTALS RATINGS
OGEN: Fundamental Ratings
OGEN
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGENREVB
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 7 days ago
70%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UAA5.040.05
+1.00%
Under Armour
BLZE8.200.08
+0.99%
Backblaze
GBR0.86N/A
+0.16%
New Concept Energy
IEX166.080.08
+0.05%
IDEX Corp
ALTO1.05N/A
N/A
Alto Ingredients

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-1.79%
ATHA - OGEN
35%
Loosely correlated
-1.23%
REVB - OGEN
34%
Loosely correlated
-2.08%
SRPT - OGEN
30%
Poorly correlated
-1.04%
CHRS - OGEN
27%
Poorly correlated
+0.88%
TBPH - OGEN
26%
Poorly correlated
N/A
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-2.08%
GNPX - REVB
48%
Loosely correlated
+1.89%
TCRT - REVB
46%
Loosely correlated
+1.07%
OGEN - REVB
34%
Loosely correlated
-1.79%
IMUX - REVB
32%
Poorly correlated
-2.85%
TOVX - REVB
31%
Poorly correlated
-0.10%
More